strattera
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.03 | $40.30 (0%) | 🛒 Add to cart |
| 20 | $2.27 | $80.61 $45.34 (44%) | 🛒 Add to cart |
| 30 | $1.68 | $120.91 $50.38 (58%) | 🛒 Add to cart |
| 60 | $0.92 | $241.82 $55.42 (77%) | 🛒 Add to cart |
| 90 | $0.67 | $362.74 $60.46 (83%) | 🛒 Add to cart |
| 120 | $0.59 | $483.65 $70.53 (85%) | 🛒 Add to cart |
| 180 | $0.56 | $725.47 $100.76 (86%) | 🛒 Add to cart |
| 270 | $0.54 | $1088.21 $146.10 (87%) | 🛒 Add to cart |
| 360 | $0.50
Best per pill | $1450.95 $181.37 (88%) | 🛒 Add to cart |
| Product dosage: 18mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.53 | $45.34 $45.34 (0%) | 🛒 Add to cart |
| 20 | $2.52 | $90.68 $50.38 (44%) | 🛒 Add to cart |
| 30 | $1.85 | $136.03 $55.42 (59%) | 🛒 Add to cart |
| 60 | $1.18 | $272.05 $70.53 (74%) | 🛒 Add to cart |
| 90 | $1.12 | $408.08 $100.76 (75%) | 🛒 Add to cart |
| 120 | $1.09 | $544.10 $130.99 (76%) | 🛒 Add to cart |
| 180 | $1.01 | $816.16 $181.37 (78%) | 🛒 Add to cart |
| 270 | $0.93 | $1224.24 $251.90 (79%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $1632.31 $317.39 (81%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.04 | $50.38 (0%) | 🛒 Add to cart |
| 20 | $2.77 | $100.76 $55.42 (45%) | 🛒 Add to cart |
| 30 | $2.02 | $151.14 $60.46 (60%) | 🛒 Add to cart |
| 60 | $1.51 | $302.28 $90.68 (70%) | 🛒 Add to cart |
| 90 | $1.46 | $453.42 $130.99 (71%) | 🛒 Add to cart |
| 120 | $1.34 | $604.56 $161.22 (73%) | 🛒 Add to cart |
| 180 | $1.12 | $906.84 $201.52 (78%) | 🛒 Add to cart |
| 270 | $1.01 | $1360.26 $272.05 (80%) | 🛒 Add to cart |
| 360 | $0.84
Best per pill | $1813.68 $302.28 (83%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $6.05 | $60.46 (0%) | 🛒 Add to cart |
| 20 | $3.53 | $120.91 $70.53 (42%) | 🛒 Add to cart |
| 30 | $3.69 | $181.37 $110.84 (39%) | 🛒 Add to cart |
| 60 | $3.36 | $362.74 $201.52 (44%) | 🛒 Add to cart |
| 90 | $2.91 | $544.10 $261.98 (52%) | 🛒 Add to cart |
| 120 | $2.52 | $725.47 $302.28 (58%) | 🛒 Add to cart |
| 180 | $2.18 | $1088.21 $392.96 (64%) | 🛒 Add to cart |
| 270 | $1.68 | $1632.31 $453.42 (72%) | 🛒 Add to cart |
| 360 | $1.40
Best per pill | $2176.42 $503.80 (77%) | 🛒 Add to cart |
Synonyms | |||
Strattera, known generically as atomoxetine, represents a significant departure from traditional stimulant-based treatments for ADHD. As a selective norepinephrine reuptake inhibitor, it works through a unique mechanism that many clinicians initially found counterintuitive. I remember when we first started prescribing it back in 2003 – the psychiatry department was divided between those who trusted the established stimulants and those willing to try this novel approach.
Strattera: Non-Stimulant ADHD Management with 24-Hour Coverage - Evidence-Based Review
1. Introduction: What is Strattera? Its Role in Modern Medicine
Strattera (atomoxetine hydrochloride) occupies a distinctive position in the ADHD treatment landscape as the first non-stimulant medication specifically approved for attention-deficit/hyperactivity disorder. Unlike conventional stimulants that primarily target dopamine pathways, Strattera focuses exclusively on norepinephrine modulation. What is Strattera used for? Primarily ADHD management in children, adolescents, and adults.
The significance of Strattera in modern psychiatry became apparent during my early years supervising the child psychiatry clinic. We had this one patient – 9-year-old Michael with combined-type ADHD and significant anxiety – whose parents refused stimulants due to concerns about addiction potential. Strattera provided us with an evidence-based alternative that didn’t carry the Schedule II classification.
2. Key Components and Bioavailability Strattera
The composition of Strattera centers around atomoxetine hydrochloride, which converts to atomoxetine – the active moiety. The standard release form comes in capsules ranging from 10mg to 100mg. Bioavailability of Strattera demonstrates interesting characteristics that practicing clinicians need to understand.
The absorption isn’t significantly affected by food, which makes dosing more flexible for patients. But here’s what they don’t emphasize enough in the package insert – the cytochrome P450 2D6 metabolism creates two distinct patient populations. Extensive metabolizers clear the drug much faster than poor metabolizers. I learned this the hard way with two siblings – Sarah and Jason – who responded completely differently to the same weight-based dosing. Genetic testing later confirmed their different metabolic statuses.
3. Mechanism of Action Strattera: Scientific Substantiation
Understanding how Strattera works requires grasping its selective norepinephrine reuptake inhibition in the prefrontal cortex. The mechanism of action differs fundamentally from stimulants – it doesn’t cause dopamine release in the nucleus accumbens, which explains its non-addictive properties.
The scientific research shows Strattera increases norepinephrine and dopamine specifically in the prefrontal cortex while leaving the reward centers relatively untouched. Think of it like improving the executive function “CEO” of the brain without overstimulating the emotional centers. The effects on the body develop gradually over several weeks, which requires managing patient expectations – something I learned after multiple frustrated parents calling about lack of immediate results.
4. Indications for Use: What is Strattera Effective For?
Strattera for Pediatric ADHD
The evidence base for children 6 years and older is robust, particularly for those with comorbid anxiety or substance use concerns. The indications for use extend beyond core ADHD symptoms to functional improvement.
Strattera for Adolescent ADHD
Adolescents often benefit from the 24-hour coverage, especially those driving or needing evening focus for homework. The treatment effect size is moderate but clinically significant.
Strattera for Adult ADHD
Many adults prefer Strattera due to smoother symptom control without the “ups and downs” of stimulants. For prevention of symptom rebound in the evenings, it’s particularly valuable.
5. Instructions for Use: Dosage and Course of Administration
The instructions for use require careful titration. For most patients, we start low and go slow:
| Population | Initial Dosage | Target Dosage | Administration |
|---|---|---|---|
| Children <70 kg | 0.5 mg/kg | 1.2 mg/kg | Once daily or divided |
| Children >70 kg & Adults | 40 mg | 80-100 mg | Once daily or divided |
The course of administration typically shows noticeable effects within 2-4 weeks, with full therapeutic benefit emerging by 6-8 weeks. Side effects often diminish after the initial adjustment period.
6. Contraindications and Drug Interactions Strattera
The contraindications include narrow-angle glaucoma and use with MAOIs. Important drug interactions occur with CYP2D6 inhibitors like paroxetine and fluoxetine. Is it safe during pregnancy? Category C – limited human data.
We had a close call early on with a college student taking St. John’s Wort who developed significant hypertension – taught us to always screen for herbal supplements. The side effects profile includes initial nausea, decreased appetite, and sometimes modest blood pressure increases.
7. Clinical Studies and Evidence Base Strattera
The clinical studies supporting Strattera include multiple randomized controlled trials. Spencer’s 2002 study in adults demonstrated significant improvement in ADHD symptoms compared to placebo. The scientific evidence shows effect sizes around 0.7, which is clinically meaningful though slightly lower than stimulants.
Physician reviews often highlight the real-world effectiveness in specific populations. The landmark study by Michelson in 2002 established the dosing parameters we still use today. What impressed me most was the consistency of response across different age groups in practice.
8. Comparing Strattera with Similar Products and Choosing Quality Medication
When comparing Strattera with similar products, the non-controlled status and different mechanism stand out. Patients often ask which ADHD medication is better – the answer depends on individual factors. How to choose involves considering:
- Comorbid conditions (anxiety, substance use)
- Need for 24-hour coverage
- Concerns about controlled substances
- Individual metabolism and side effect profile
The quality considerations are straightforward since it’s a single-entity prescription medication rather than a supplement.
9. Frequently Asked Questions (FAQ) about Strattera
What is the recommended course of Strattera to achieve results?
Most patients notice initial benefits within 2-4 weeks, but full therapeutic effect typically requires 6-8 weeks of consistent dosing.
Can Strattera be combined with stimulant medications?
Sometimes, under careful supervision – we’ve used low-dose Strattera with shorter-acting stimulants for patients needing round-the-clock coverage with flexible dosing.
How does Strattera compare to Intuniv?
Both are non-stimulants, but different mechanisms – Strattera is SNRI while Intuniv is alpha-2 agonist. Choice depends on individual profile and response.
Are there withdrawal concerns with Strattera?
No significant withdrawal syndrome, but gradual taper is still recommended to monitor for symptom return.
10. Conclusion: Validity of Strattera Use in Clinical Practice
The risk-benefit profile favors Strattera for many patients, particularly those with comorbid anxiety, substance use concerns, or need for continuous coverage. The validity of Strattera use in clinical practice is well-established through both clinical trials and real-world experience.
I’ve been following some of my earliest Strattera patients for over 15 years now. There’s Maria, now in her late 20s, who started at age 12 after stimulants caused significant anxiety. She’s now completing her PhD in neuroscience – still on Strattera, still thriving. Then there’s David, the construction company owner who needed steady focus without the emotional blunting he experienced with stimulants. His business tripled in size after finding the right Strattera dosage.
The development team initially struggled with the slow onset – nearly abandoned the project multiple times. The marketing department wanted immediate results, but the clinical team insisted the gradual build provided unique benefits. Turns out we were both right – the slow start frustrates patients initially, but the steady state provides something stimulants can’t: consistent, predictable symptom control without rebounds or emotional rollercoasters.
Just last week, a mother brought her daughter in for follow-up. “She’s like herself, just more organized,” she told me. That’s the feedback I’ve heard dozens of times over the years. Not “zombified” or “over-medicated” – just themselves, with better executive function. That’s the real success metric they don’t teach in pharmacology lectures.